KVUE Kenvue
FY2024 10-K
Kenvue (KVUE) filed its fiscal year 2024 10-K annual report with the SEC on Feb 24, 2025. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.
AI Filing AnalysisFY2024 10-K
Management Discussion & Analysis
- • Operating cash flow $1.8B down $1.4B YoY from $3.2B in fiscal 2023, decline driven by working capital changes
- • Financing cash outflow $1.6B in fiscal 2024, included $1.55B dividends and $235M share repurchases; repurchased 10.86M shares for $235M
Risk Factors
- • Talc-related litigation risk for Johnson’s® Baby Powder sold outside US/Canada, with talc-based powder discontinued globally in 2023
- • Global operations exposed to foreign currency fluctuations and geopolitical conflicts impacting supply and costs
Financial SummaryXBRL
Revenue
$15.5B
Net Income
$1.0B
Gross Margin
58.0%
Operating Margin
11.9%
Net Margin
6.7%
ROE
10.7%
Total Assets
$25.6B
EPS (Diluted)
$0.54
Operating Cash Flow
$1.8B
Source: XBRL data from Kenvue FY2024 10-K filing on SEC EDGAR. All figures in USD.
Other Kenvue Annual Reports
Get deeper insights on Kenvue
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.